Biosenta Inc.
ZRO
CNSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -50.00% | 50.00% | -80.00% | -- | 0.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -50.00% | 50.00% | -80.00% | -- | 0.00% |
| Cost of Revenue | 0.00% | -99.15% | 2,500.00% | -- | 0.00% |
| Gross Profit | 0.00% | 100.43% | -725.00% | -- | 0.00% |
| SG&A Expenses | 0.28% | 36.98% | 70.27% | 33.95% | -31.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.55% | 21.28% | 72.79% | 8.70% | -30.54% |
| Operating Income | 0.49% | -21.26% | -73.10% | -8.66% | 30.54% |
| Income Before Tax | -94.33% | -434.02% | -66.41% | 85.33% | 59.04% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -94.33% | -434.02% | -66.41% | 85.33% | 59.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -94.33% | -434.02% | -66.41% | 85.33% | 59.04% |
| EBIT | 0.49% | -21.26% | -73.10% | -8.66% | 30.54% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -70.13% | -252.78% | -66.67% | 87.41% | 65.63% |
| Normalized Basic EPS | -70.83% | 39.58% | -66.67% | 9.33% | 65.71% |
| EPS Diluted | -70.13% | -252.78% | -66.67% | 87.41% | 65.63% |
| Normalized Diluted EPS | -70.83% | 39.58% | -66.67% | 9.33% | 65.71% |
| Average Basic Shares Outstanding | 15.02% | 118.66% | 0.23% | 16.26% | 18.71% |
| Average Diluted Shares Outstanding | 15.02% | 118.66% | 0.23% | 16.26% | 18.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
